312 related articles for article (PubMed ID: 9422324)
21. Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix.
Utsugi K; Shimizu Y; Akiyama F; Umezawa S; Hasumi K
Gynecol Oncol; 2004 Jan; 92(1):64-70. PubMed ID: 14751140
[TBL] [Abstract][Full Text] [Related]
22. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors.
Goldblum J; Hart WR
Am J Surg Pathol; 1995 Oct; 19(10):1124-37. PubMed ID: 7573671
[TBL] [Abstract][Full Text] [Related]
23. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
[TBL] [Abstract][Full Text] [Related]
24. Papillary-serous adenocarcinoma of the uterine cervix during tamoxifen therapy after bilateral breast cancer.
Watrowski R; Striepecke E; Jäger C; Bauknecht T; Horst C
Anticancer Res; 2012 Nov; 32(11):5075-8. PubMed ID: 23155282
[TBL] [Abstract][Full Text] [Related]
25. Paratesticular serous papillary carcinoma. A report of six cases.
Jones MA; Young RH; Srigley JR; Scully RE
Am J Surg Pathol; 1995 Dec; 19(12):1359-65. PubMed ID: 7503358
[TBL] [Abstract][Full Text] [Related]
26. Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases.
Bagué S; Rodríguez IM; Prat J
Am J Surg Pathol; 2004 May; 28(5):601-7. PubMed ID: 15105647
[TBL] [Abstract][Full Text] [Related]
27. Serous papillary carcinoma of the cervix.
Rose PG; Reale FR
Gynecol Oncol; 1993 Sep; 50(3):361-4. PubMed ID: 8406202
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical characterization of endocervical papillary serous carcinoma.
Nofech-Mozes S; Rasty G; Ismiil N; Covens A; Khalifa MA
Int J Gynecol Cancer; 2006; 16 Suppl 1():286-92. PubMed ID: 16515605
[TBL] [Abstract][Full Text] [Related]
29. Mixed papillary transitional cell carcinoma and adenocarcinoma of the uterine cervix: a clinicopathologic study of three cases.
Robinson CE; Sarode VR; Albores-Saavedra J
Int J Gynecol Pathol; 2003 Jul; 22(3):220-5. PubMed ID: 12819386
[TBL] [Abstract][Full Text] [Related]
30. Papillary serous carcinoma of the cervix: ultrasonographic findings.
Geisler JP; Hiett AK; Geisler HE; Shade A; Cudahy TJ; Moore DK
Eur J Gynaecol Oncol; 1998; 19(6):519-21. PubMed ID: 10215431
[TBL] [Abstract][Full Text] [Related]
31. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
[TBL] [Abstract][Full Text] [Related]
32. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
Bosković V; Glisić A; Petković S
Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
[TBL] [Abstract][Full Text] [Related]
33. Adenoid basal epitheliomas of the uterine cervix: a reevaluation of distinctive cervical basaloid lesions currently classified as adenoid basal carcinoma and adenoid basal hyperplasia.
Brainard JA; Hart WR
Am J Surg Pathol; 1998 Aug; 22(8):965-75. PubMed ID: 9706976
[TBL] [Abstract][Full Text] [Related]
34. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; McKee B; Hoskins WJ; Barakat RR
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):79-85. PubMed ID: 12182977
[TBL] [Abstract][Full Text] [Related]
35. Villoglandular papillary adenocarcinoma of the uterine cervix.
Collinet P; Prolongeau JF; Vaneecloo S
Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):101-3. PubMed ID: 10471150
[TBL] [Abstract][Full Text] [Related]
36. Endometrioid endometrial adenocarcinoma with psammoma bodies.
Parkash V; Carcangiu ML
Am J Surg Pathol; 1997 Apr; 21(4):399-406. PubMed ID: 9130986
[TBL] [Abstract][Full Text] [Related]
37. Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases.
Young RH; Scully RE
Cancer; 1989 May; 63(9):1773-9. PubMed ID: 2702584
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Lin HH; Cheng WF; Chan KW; Chang DY; Chen CK; Huang SC
Obstet Gynecol; 1996 Aug; 88(2):274-9. PubMed ID: 8692515
[TBL] [Abstract][Full Text] [Related]
39. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
40. Grade 1 peritoneal serous carcinomas: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors.
Weir MM; Bell DA; Young RH
Am J Surg Pathol; 1998 Jul; 22(7):849-62. PubMed ID: 9669347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
